Skip to main content
SpringerLink
Log in

Entecavir

A Viewpoint by Robert G. Gish

  • Adis Drug Evaluations
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dodd RY, Nath N. Increased risk for lethal forms of liver disease among HBsAg-positive blood donors in the United States. J Virol Methods 1987; 17(1–2): 81–94.

    Article  PubMed  CAS  Google Scholar 

  2. Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis 2004; 24 Suppl. 1: 3–10

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Transplantation and the Division of Hepatology and Complex GI, Physicians Foundation, California Pacific Medical Center, San Francisco, California, USA

    Robert G. Gish

Authors
  1. Robert G. Gish
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gish, R.G. Entecavir. Drugs 66, 1623 (2006). https://doi.org/10.2165/00003495-200666120-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666120-00010

Search

Navigation